Research Applications Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist investigated in laboratory and experimental research settings for its interaction with metabolic, appetite-related, and glucose-regulation pathways
Every patient at the Sanctuary Wellness Institute begins with a comprehensive telehealth evaluation to ensure Semaglutide or Tirzepatide is safe and appropriate based on their individual health profile
One study involved over 18,000 adults who were overweight or had obesity, with results showing that people taking tirzepatide were more likely to lose at least 5% of their body weight than those taking semaglutide
For example, they could look at other covered options on their plans formulary, use savings programs from manufacturers, or look into direct-to-consumer sales options offered by manufacturers
Many laxatives and stool softeners are available over the counter (OTC) and without a prescription